PAHO flags very high measles risk ahead of South America gatherings

With 55,792 confirmed measles cases and 77 deaths across the Americas in 2026, PAHO warns that upcoming religious mass gatherings in South America could accelerate transmission in a region where vaccination coverage falls below the threshold needed to prevent outbreaks.

A large teal canopy shelters a dense crowd of small silhouettes while burnt-orange drops fall around and through gaps in its edges.

HEALTH SYSTEMS & DISEASE BURDEN · OUTBREAK RESPONSE · NOVEMBER 15, 2026 · AMERICAS

Fifty-five thousand confirmed measles cases in a single calendar year is the highest count the Pan American Health Organization (PAHO) has recorded for the Americas in at least 22 years. As of 3 October 2026, that figure stood at 55,792 — with 77 deaths across 17 countries and territories — and PAHO, the regional health body for the Americas headquartered in Washington, D.C., has now issued a fresh risk assessment rating the risk of further spread as ‘very high,’ according to a PAHO announcement dated 9 October 2026. The immediate trigger is a set of religious mass gatherings expected in Argentina, Peru and Uruguay in the coming months, events that PAHO warns could function as amplifiers of transmission across a region whose vaccination coverage already falls short of the level needed to interrupt outbreaks.

The scale of the 2026 surge is striking in its own terms. The 55,792 confirmed cases reported between 4 January and 3 October represent a 4.8-fold increase compared with the same period in 2025, according to PAHO’s 9 October announcement; the organization’s 8 October risk assessment puts the increase at 4.6-fold. Five countries — Guatemala, Mexico, the United States, Peru, and Canada — account for 99.5% of confirmed regional cases. Cases have also been reported in Argentina, Belize, Bolivia, Bonaire, Brazil, Chile, Colombia, Costa Rica, El Salvador, Honduras, Panama, and Uruguay, according to the same PAHO announcement. By mid-July, cases had already reached more than three times the 15,011 confirmed for all of 2025, according to PAHO’s 8 August statement. PAHO’s 6 November situation report puts the count at 57,666 confirmed cases and 81 deaths through 31 October, a 4.7-fold increase.

55,792

PAHO reported 55,792 confirmed measles cases across 17 countries and territories in the Americas between 4 January and 3 October 2026.

An immunity gap that predates the gatherings

The structural vulnerability driving PAHO’s concern is not the gatherings themselves but the immunity deficit they will expose. Regional coverage reached 88% for the first dose of the measles, mumps and rubella (MMR) vaccine and 85% for the second dose in 2025, according to PAHO — both below the 95% threshold the organization identifies as necessary to prevent outbreaks. An estimated 1.6 million children in the Americas received no dose of measles vaccine in 2025, per PAHO data. The organization attributes the coverage shortfall to setbacks accumulated during the COVID-19 pandemic, vaccine hesitancy in some communities, operational delivery challenges, and barriers to access among Indigenous peoples, migrants, and displaced populations.

‘Measles is highly contagious, and we are seeing the consequences of gaps in vaccination coverage across the Americas,’ said Dr. Jarbas Barbosa, PAHO Director, in the 9 October statement. ‘People need to protect their children with the very effective and safe measles, mumps and rubella (MMR) vaccine, and countries have to close immunity gaps, strengthen surveillance and ensure that they can detect and respond rapidly to cases, particularly as increased travel and large gatherings create more opportunities for the virus to spread.’

The mass-gathering dimension adds a specific operational pressure. Measles can be transmitted before the characteristic rash appears, meaning infected travelers may expose others before any clinical signal is visible. Dr. Daniel Salas, Executive Manager of Comprehensive Immunization at PAHO, stated in the same announcement that people aged six months and older without evidence of vaccination should receive a dose of measles-rubella vaccine before traveling or attending a gathering, ‘preferably at least two weeks in advance.’ PAHO said it is supporting preparedness for upcoming mass gatherings in South America expected to involve significant national and international population movement, and is also supporting laboratory-based surveillance and genomic monitoring across the Region.

The procurement and response window

For governments and procurement bodies, the 8 October risk assessment compresses the operational timeline. Supplementary immunization activities — the mechanism PAHO recommends for closing immunity gaps — require vaccine supply, cold-chain logistics, and community outreach to be in place before gatherings occur, not after. PAHO’s 2025 Annual Report states the Regional Revolving Funds procured more than USD 900 million in vaccines, health technologies, and supplies and delivered over 230 million vaccine doses in 2025.

The counterpoint to urgency is operational. The same structural factors PAHO identifies as driving the immunity gap in the first place, including operational challenges in vaccine delivery and barriers to health services, are the factors that would slow any rapid response. A risk assessment that correctly identifies the threat does not automatically resolve the logistical constraints that created it. PAHO’s own assessment warns that high demand and limited vaccine supply could lengthen waiting times for measles vaccine.

Children under five and populations experiencing malnutrition or limited access to health services have been disproportionately affected during recent outbreaks in the Region, according to PAHO. The 8 October assessment also notes the detection of cases in new geographic areas and the impact on Indigenous populations and on communities or groups reluctant to get vaccinated — patterns that suggest the burden is not distributed evenly across the countries reporting cases.

What to Watch

  1. Whether South American governments announce supplementary immunization campaigns in advance of the identified religious mass gatherings, and on what timeline relative to the events
  2. Updated PAHO case counts for the Region, particularly whether the three host countries named in PAHO’s assessment — Argentina, Peru and Uruguay — see acceleration linked to gathering-related population movement
  3. Whether PAHO issues a further updated risk assessment following the mass gatherings, and whether the ‘very high’ classification is revised upward, maintained, or downgraded
THE HEALTHSIGNALS BRIEF
A fortnightly PDF compiling our analysis on pharma, medical devices, health policy and epidemiology across Latin America and the United States.
Step 1 of 2 · Free. Work email for instant access. Unsubscribe anytime. By subscribing you agree to receive The HealthSignals Brief by email and accept our Privacy Policy.

The practical implication for governments is that the mass-gathering window is not the origin of the problem but a stress test of whether the underlying immunity deficit has been addressed.

Measles in the Americas · 4 January–3 October 2026

Indicator Cases Deaths
Confirmed total 55,792 77
Countries and territories reporting 17 —
Share from Guatemala, Mexico, US, Peru, Canada 99.5% —
Increase vs same period 2025 4.8-fold —

Source: PAHO announcement, 9 October 2026

Why this is relevant

Patients

Children under five, Indigenous communities, migrants, and displaced populations have been disproportionately affected during recent outbreaks, according to PAHO. An estimated 1.6 million children in the Americas received no measles vaccine dose in 2025, and upcoming religious mass gatherings could increase exposure for unvaccinated individuals of all ages.

Industry

PAHO’s ‘very high’ risk classification, and its 7 August call for supplementary vaccination activities to close immunity gaps, could indicate near-term procurement demand across multiple South American markets. PAHO’s Regional Revolving Funds procured more than USD 900 million in vaccines and health technologies in 2025.

Payers

Governments face a compressed operational window to fund supplementary immunization campaigns before mass gatherings occur. The structural barriers PAHO identifies — operational delivery challenges and access gaps among Indigenous and migrant populations — may constrain how quickly procurement decisions translate into administered doses.

Regulators

PAHO has issued a formal risk assessment dated 8 October 2026 classifying regional measles spread risk as ‘very high’ and is urging countries to strengthen epidemiological surveillance, laboratory-based surveillance, and rapid outbreak response, with specific preparedness support directed at South American countries expecting significant population movement.

Sources: PAHO: PAHO assesses risk of measles spread as very high ahead of religious mass gatherings in the Americas · PAHO: Public health risk assessment of measles in the context of religious mass gatherings in South America, 8 October 2026 · PAHO: Epidemiological Alert — Measles in the Americas Region, 7 August 2026 · PAHO: PAHO urges countries to strengthen vaccination and surveillance amid rising measles cases in the Americas · PAHO: Driving innovation delivering impact — 2025 Annual Report of the Pan American Health Organization · PAHO: Public health risk assessment of measles in the context of religious mass gatherings in South America, 8 October 2026 (PDF) · PAHO: Situation Report 15 — Measles in the Americas Region, 6 November 2026

THE HEALTHSIGNALS BRIEF

A fortnightly PDF compiling our analysis on pharma, medical devices, health policy and epidemiology across Latin America and the United States.

Built for pharma, market-access, regulatory, policy and investor teams, with the main findings of our gated reports included.

Your subscription could not be validated.
You have successfully subscribed.

Comments

Related